Effects  	Effects  	 NNS	O
of  	of  	 IN	O
flunixin  	flunixin  	 NN	B-NP
on  	on  	 IN	O
cardiorespiratory 	cardiorespiratory 	 NN	B-NP
,  	,  	 ,	O
plasma  	plasma  	 JJ	B-NP
lactate  	lactate  	 NN	I-NP
and  	and  	 CC	O
stride  	stride  	 JJ	O
length  	length  	 NN	O
responses  	responses  	 NNS	O
to  	to  	 TO	O
intense  	intense  	 JJ	O
treadmill  	treadmill  	 JJ	B-NP
exercise  	exercise  	 NN	I-NP
in  	in  	 IN	O
Standardbred  	Standardbred  	 NNP	B-NP
trotters  	trotters  	 NN	I-NP
Since  	Since  	 IN	O
nonsteroidal  	nonsteroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
flunixin 	flunixin 	 NN	B-NP
,  	,  	 ,	O
on  	on  	 IN	O
account  	account  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
anti-inflammatory  	anti-inflammatory  	 JJ	B-NP
and  	and  	 CC	O
analgesic  	analgesic  	 JJ	B-NP
properties 	properties 	 NNS	I-NP
,  	,  	 ,	O
are  	are  	 VBP	O
used  	used  	 VBN	O
in  	in  	 IN	O
both  	both  	 DT	O
racing  	racing  	 NN	O
and  	and  	 CC	O
equestrian  	equestrian  	 JJ	B-NP
sport  	sport  	 NN	I-NP
horses 	horses 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
question  	question  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
raised  	raised  	 VBN	O
as  	as  	 RB	O
to  	to  	 TO	O
whether  	whether  	 IN	O
these  	these  	 DT	O
drugs  	drugs  	 NNS	O
affect  	affect  	 VBP	O
the  	the  	 DT	O
physiological  	physiological  	 JJ	B-NP
responses  	responses  	 NNS	I-NP
to  	to  	 TO	O
exercise  	exercise  	 VB	O
and  	and  	 CC	O
thus  	thus  	 RB	O
performance  	performance  	 NN	B-NP
potential 	potential 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
aims  	aims  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
investigation  	investigation  	 NN	B-NP
were  	were  	 VBD	O
to  	to  	 TO	O
study  	study  	 VB	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
flunixin  	flunixin  	 NN	B-NP
on  	on  	 IN	O
cardiorespiratory 	cardiorespiratory 	 NN	B-NP
,  	,  	 ,	O
metabolic  	metabolic  	 NN	O
and  	and  	 CC	O
locomotor  	locomotor  	 JJ	B-NP
parameters  	parameters  	 NNS	I-NP
in  	in  	 IN	O
horses  	horses  	 NNS	O
during  	during  	 IN	O
intense  	intense  	 JJ	O
treadmill  	treadmill  	 JJ	B-NP
exercise 	exercise 	 NN	I-NP
.  	.  	 .	O
Six  	Six  	 CD	O
Standardbred  	Standardbred  	 JJ	B-NP
trotters  	trotters  	 NN	I-NP
underwent  	underwent  	 VBD	O
an  	an  	 DT	O
incremental  	incremental  	 JJ	B-NP
treadmill  	treadmill  	 JJ	I-NP
exercise  	exercise  	 NN	I-NP
test  	test  	 NN	I-NP
to  	to  	 TO	O
fatigue 	fatigue 	 VB	O
,  	,  	 ,	O
without  	without  	 IN	O
drug  	drug  	 NN	O
and  	and  	 CC	O
then  	then  	 RB	O
after  	after  	 IN	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	I-NP
flunixin  	flunixin  	 JJ	I-NP
meglumine  	meglumine  	 NNS	I-NP
( 	( 	 -LRB-	O
1.1  	1.1  	 FW	O
mg 	mg 	 FW	B-NP
/ 	/ 	 FW	I-NP
kg  	kg  	 FW	I-NP
bwt  	bwt  	 FW	I-NP
i.m. 	i.m. 	 FW	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Heart  	Heart  	 NN	B-NP
rate  	rate  	 NN	I-NP
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
oxygen  	oxygen  	 NN	O
uptake  	uptake  	 NNS	O
and  	and  	 CC	O
stride  	stride  	 JJ	O
length  	length  	 NN	O
were  	were  	 VBD	O
measured  	measured  	 VBN	O
and  	and  	 CC	O
venous  	venous  	 JJ	B-NP
blood  	blood  	 NN	I-NP
samples  	samples  	 NNS	I-NP
drawn  	drawn  	 VBN	O
repeatedly  	repeatedly  	 RB	O
during  	during  	 IN	O
the  	the  	 DT	O
test 	test 	 NN	O
.  	.  	 .	O
Heart  	Heart  	 NN	B-NP
rates  	rates  	 NNS	I-NP
were  	were  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
at  	at  	 IN	O
submaximal  	submaximal  	 JJ	B-NP
speeds 	speeds 	 NNS	I-NP
,  	,  	 ,	O
while  	while  	 IN	O
the  	the  	 DT	O
velocity  	velocity  	 NN	B-NP
causing  	causing  	 VBG	O
a  	a  	 DT	O
HR  	HR  	 NNP	B-NP
of  	of  	 IN	O
200  	200  	 CD	O
beats 	beats 	 CD	B-NP
/ 	/ 	 CD	I-NP
min  	min  	 NNS	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
decreased  	decreased  	 VBN	O
after  	after  	 IN	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
flunixin 	flunixin 	 NN	B-NP
.  	.  	 .	O
Maximal  	Maximal  	 NNP	B-NP
HR  	HR  	 NNP	I-NP
and  	and  	 CC	O
plasma  	plasma  	 JJ	B-NP
lactate  	lactate  	 JJ	I-NP
concentration  	concentration  	 NN	I-NP
5  	5  	 CD	O
min  	min  	 NN	B-NP
after  	after  	 IN	O
exercise  	exercise  	 NN	O
were  	were  	 VBD	O
unchanged  	unchanged  	 JJ	O
after  	after  	 IN	O
medication 	medication 	 NN	O
.  	.  	 .	O
Flunixin  	Flunixin  	 NNP	B-NP
caused  	caused  	 VBD	O
higher  	higher  	 JJR	O
plasma  	plasma  	 JJ	B-NP
lactate  	lactate  	 JJ	I-NP
concentrations  	concentrations  	 NNS	I-NP
at  	at  	 IN	O
all  	all  	 DT	O
speeds  	speeds  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
lactate  	lactate  	 JJ	B-NP
threshold  	threshold  	 NN	I-NP
was  	was  	 VBD	O
decreased 	decreased 	 VBN	O
,  	,  	 ,	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
baseline  	baseline  	 NN	B-NP
values 	values 	 NNS	I-NP
.  	.  	 .	O
Oxygen  	Oxygen  	 NNP	O
uptake  	uptake  	 VBD	O
levelled  	levelled  	 VBN	O
off  	off  	 RP	O
at  	at  	 IN	O
the  	the  	 DT	O
highest  	highest  	 JJS	O
velocities  	velocities  	 NN	O
and  	and  	 CC	O
did  	did  	 VBD	O
not  	not  	 RB	O
change  	change  	 VB	O
after  	after  	 IN	O
flunixin  	flunixin  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
Stride  	Stride  	 JJ	O
length  	length  	 NN	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
after  	after  	 IN	O
treatment 	treatment 	 NN	O
,  	,  	 ,	O
although  	although  	 IN	O
not  	not  	 RB	O
at  	at  	 IN	O
the  	the  	 DT	O
highest  	highest  	 JJS	O
velocities 	velocities 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
increased  	increased  	 JJ	O
HR  	HR  	 NNP	B-NP
and  	and  	 CC	O
lactate  	lactate  	 JJ	B-NP
responses  	responses  	 NNS	I-NP
to  	to  	 TO	O
exercise  	exercise  	 VB	O
after  	after  	 IN	O
flunixin  	flunixin  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
it  	it  	 PRP	O
does  	does  	 VBZ	O
influence  	influence  	 NN	O
physiological  	physiological  	 NN	B-NP
responses 	responses 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
does  	does  	 VBZ	O
not  	not  	 RB	O
improve  	improve  	 VB	O
the  	the  	 DT	O
performance  	performance  	 NN	B-NP
potential  	potential  	 NN	I-NP
of  	of  	 IN	O
clinically  	clinically  	 JJ	O
healthy  	healthy  	 JJ	O
horses 	horses 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
lengthened  	lengthened  	 JJ	O
stride  	stride  	 NN	O
during  	during  	 IN	O
submaximal  	submaximal  	 JJ	B-NP
exercise  	exercise  	 NN	I-NP
after  	after  	 IN	O
medication  	medication  	 NN	O
could  	could  	 MD	O
imply  	imply  	 VB	O
undetected  	undetected  	 JJ	O
subclinical  	subclinical  	 JJ	B-NP
lameness 	lameness 	 NN	I-NP
,  	,  	 ,	O
masked  	masked  	 VBN	O
in  	in  	 IN	O
some  	some  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
horses 	horses 	 NNS	O
,  	,  	 ,	O
i.e.  	i.e.  	 VBZ	O
they  	they  	 PRP	O
have  	have  	 VBP	O
performed  	performed  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
longer  	longer  	 JJR	O
stride  	stride  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
cost  	cost  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
heart  	heart  	 NN	B-NP
rate  	rate  	 NN	I-NP
and  	and  	 CC	O
an  	an  	 DT	O
increased  	increased  	 JJ	O
lactate  	lactate  	 JJ	B-NP
concentration 	concentration 	 NN	I-NP
.  	.  	 .	O
